Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Nausea And Vomiting Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Serotonin Receptor Antagonist 1.4.3 Neurokinin NK1 Receptor Antagonist 1.4.4 Other 1.5 Market by Application 1.5.1 Global Nausea And Vomiting Treatment Market Share by Application: 2020 VS 2026 1.5.2 CINV 1.5.3 PONV 1.5.4 Motion Sickness 1.5.5 Pregnancy 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Nausea And Vomiting Treatment Market Perspective (2015-2026) 2.2 Nausea And Vomiting Treatment Growth Trends by Regions 2.2.1 Nausea And Vomiting Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Nausea And Vomiting Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Nausea And Vomiting Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Nausea And Vomiting Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Nausea And Vomiting Treatment Players by Market Size 3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2015-2020) 3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Nausea And Vomiting Treatment Market Concentration Ratio 3.2.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2019 3.3 Nausea And Vomiting Treatment Key Players Head office and Area Served 3.4 Key Players Nausea And Vomiting Treatment Product Solution and Service 3.5 Date of Enter into Nausea And Vomiting Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2015-2020) 4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2021-2026) 5 Nausea And Vomiting Treatment Breakdown Data by Application (2015-2026) 5.1 Global Nausea And Vomiting Treatment Market Size by Application (2015-2020) 5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Nausea And Vomiting Treatment Market Size (2015-2020) 6.2 Nausea And Vomiting Treatment Key Players in North America (2019-2020) 6.3 North America Nausea And Vomiting Treatment Market Size by Type (2015-2020) 6.4 North America Nausea And Vomiting Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Nausea And Vomiting Treatment Market Size (2015-2020) 7.2 Nausea And Vomiting Treatment Key Players in Europe (2019-2020) 7.3 Europe Nausea And Vomiting Treatment Market Size by Type (2015-2020) 7.4 Europe Nausea And Vomiting Treatment Market Size by Application (2015-2020) 8 China 8.1 China Nausea And Vomiting Treatment Market Size (2015-2020) 8.2 Nausea And Vomiting Treatment Key Players in China (2019-2020) 8.3 China Nausea And Vomiting Treatment Market Size by Type (2015-2020) 8.4 China Nausea And Vomiting Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Nausea And Vomiting Treatment Market Size (2015-2020) 9.2 Nausea And Vomiting Treatment Key Players in Japan (2019-2020) 9.3 Japan Nausea And Vomiting Treatment Market Size by Type (2015-2020) 9.4 Japan Nausea And Vomiting Treatment Market Size by Application (2015-2020) 10Key Players Profiles 10.1 Merck & Co. Inc. 10.1.1 Merck & Co. Inc. Company Details 10.1.2 Merck & Co. Inc. Business Overview and Its Total Revenue 10.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction 10.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2015-2020)) 10.1.5 Merck & Co. Inc. Recent Development 10.2 Helsinn Group 10.2.1 Helsinn Group Company Details 10.2.2 Helsinn Group Business Overview and Its Total Revenue 10.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction 10.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.2.5 Helsinn Group Recent Development 10.3 Unimed Pharmaceuticals (AbbVie Inc.) 10.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details 10.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview and Its Total Revenue 10.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction 10.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development 10.4 Kyowa Kirin 10.4.1 Kyowa Kirin Company Details 10.4.2 Kyowa Kirin Business Overview and Its Total Revenue 10.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction 10.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.4.5 Kyowa Kirin Recent Development 10.5 Sanofi 10.5.1 Sanofi Company Details 10.5.2 Sanofi Business Overview and Its Total Revenue 10.5.3 Sanofi Nausea And Vomiting Treatment Introduction 10.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.5.5 Sanofi Recent Development 10.6 Qilu Pharma 10.6.1 Qilu Pharma Company Details 10.6.2 Qilu Pharma Business Overview and Its Total Revenue 10.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction 10.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.6.5 Qilu Pharma Recent Development 10.7 Teva Pharmaceutical Industries Ltd. 10.7.1 Teva Pharmaceutical Industries Ltd. Company Details 10.7.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue 10.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction 10.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.7.5 Teva Pharmaceutical Industries Ltd. Recent Development 10.8 Taiji group 10.8.1 Taiji group Company Details 10.8.2 Taiji group Business Overview and Its Total Revenue 10.8.3 Taiji group Nausea And Vomiting Treatment Introduction 10.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.8.5 Taiji group Recent Development 10.9 Novartis 10.9.1 Novartis Company Details 10.9.2 Novartis Business Overview and Its Total Revenue 10.9.3 Novartis Nausea And Vomiting Treatment Introduction 10.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.9.5 Novartis Recent Development 10.10 Heron Therapeutics 10.10.1 Heron Therapeutics Company Details 10.10.2 Heron Therapeutics Business Overview and Its Total Revenue 10.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction 10.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.10.5 Heron Therapeutics Recent Development 10.11 Atnahs Pharma UK Limited 10.11.1 Atnahs Pharma UK Limited Company Details 10.11.2 Atnahs Pharma UK Limited Business Overview and Its Total Revenue 10.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Introduction 10.11.4 Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.11.5 Atnahs Pharma UK Limited Recent Development 10.12 Mylan 10.12.1 Mylan Company Details 10.12.2 Mylan Business Overview and Its Total Revenue 10.12.3 Mylan Nausea And Vomiting Treatment Introduction 10.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.12.5 Mylan Recent Development 10.13 Duchesnay 10.13.1 Duchesnay Company Details 10.13.2 Duchesnay Business Overview and Its Total Revenue 10.13.3 Duchesnay Nausea And Vomiting Treatment Introduction 10.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.13.5 Duchesnay Recent Development 10.14 Tesaro 10.14.1 Tesaro Company Details 10.14.2 Tesaro Business Overview and Its Total Revenue 10.14.3 Tesaro Nausea And Vomiting Treatment Introduction 10.14.4 Tesaro Revenue in Nausea And Vomiting Treatment Business (2015-2020) 10.14.5 Tesaro Recent Development 11Analyst's Viewpoints/Conclusions 12Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

List of Tables Table 1. Nausea And Vomiting Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Nausea And Vomiting Treatment Revenue Table 3. Ranking of Global Top Nausea And Vomiting Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Serotonin Receptor Antagonist Table 6. Key Players of Neurokinin NK1 Receptor Antagonist Table 7. Key Players of Other Table 8. Global Nausea And Vomiting Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Nausea And Vomiting Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Nausea And Vomiting Treatment Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Nausea And Vomiting Treatment Market Share by Regions (2015-2020) Table 12. Global Nausea And Vomiting Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Nausea And Vomiting Treatment Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Nausea And Vomiting Treatment Market Growth Strategy Table 18. Main Points Interviewed from Key Nausea And Vomiting Treatment Players Table 19. Global Nausea And Vomiting Treatment Revenue by Players (2015-2020) (Million US$) Table 20. Global Nausea And Vomiting Treatment Market Share by Players (2015-2020) Table 21. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nausea And Vomiting Treatment as of 2019) Table 22. Global Nausea And Vomiting Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Nausea And Vomiting Treatment Product Solution and Service Table 25. Date of Enter into Nausea And Vomiting Treatment Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Nausea And Vomiting Treatment Market Size by Type (2015-2020) (Million US$) Table 28. Global Nausea And Vomiting Treatment Market Size Share by Type (2015-2020) Table 29. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Nausea And Vomiting Treatment Market Size Share by Application (2015-2020) Table 31. Global Nausea And Vomiting Treatment Market Size by Application (2015-2020) (Million US$) Table 32. Global Nausea And Vomiting Treatment Market Size Share by Application (2021-2026) Table 33. North America Key Players Nausea And Vomiting Treatment Revenue (2019-2020) (Million US$) Table 34. North America Key Players Nausea And Vomiting Treatment Market Share (2019-2020) Table 35. North America Nausea And Vomiting Treatment Market Size by Type (2015-2020) (Million US$) Table 36. North America Nausea And Vomiting Treatment Market Share by Type (2015-2020) Table 37. North America Nausea And Vomiting Treatment Market Size by Application (2015-2020) (Million US$) Table 38. North America Nausea And Vomiting Treatment Market Share by Application (2015-2020) Table 39. Europe Key Players Nausea And Vomiting Treatment Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Nausea And Vomiting Treatment Market Share (2019-2020) Table 41. Europe Nausea And Vomiting Treatment Market Size by Type (2015-2020) (Million US$) Table 42. Europe Nausea And Vomiting Treatment Market Share by Type (2015-2020) Table 43. Europe Nausea And Vomiting Treatment Market Size by Application (2015-2020) (Million US$) Table 44. Europe Nausea And Vomiting Treatment Market Share by Application (2015-2020) Table 45. China Key Players Nausea And Vomiting Treatment Revenue (2019-2020) (Million US$) Table 46. China Key Players Nausea And Vomiting Treatment Market Share (2019-2020) Table 47. China Nausea And Vomiting Treatment Market Size by Type (2015-2020) (Million US$) Table 48. China Nausea And Vomiting Treatment Market Share by Type (2015-2020) Table 49. China Nausea And Vomiting Treatment Market Size by Application (2015-2020) (Million US$) Table 50. China Nausea And Vomiting Treatment Market Share by Application (2015-2020) Table 51. Japan Key Players Nausea And Vomiting Treatment Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Nausea And Vomiting Treatment Market Share (2019-2020) Table 53. Japan Nausea And Vomiting Treatment Market Size by Type (2015-2020) (Million US$) Table 54. Japan Nausea And Vomiting Treatment Market Share by Type (2015-2020) Table 55. Japan Nausea And Vomiting Treatment Market Size by Application (2015-2020) (Million US$) Table 56. Japan Nausea And Vomiting Treatment Market Share by Application (2015-2020) Table 57. Merck & Co. Inc. Company Details Table 58. Merck & Co. Inc. Business Overview Table 59. Merck & Co. Inc. Product Table 60. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 61. Merck & Co. Inc. Recent Development Table 62. Helsinn Group Company Details Table 63. Helsinn Group Business Overview Table 64. Helsinn Group Product Table 65. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 66. Helsinn Group Recent Development Table 67. Unimed Pharmaceuticals (AbbVie Inc.) Company Details Table 68. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview Table 69. Unimed Pharmaceuticals (AbbVie Inc.) Product Table 70. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 71. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development Table 72. Kyowa Kirin Company Details Table 73. Kyowa Kirin Business Overview Table 74. Kyowa Kirin Product Table 75. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 76. Kyowa Kirin Recent Development Table 77. Sanofi Company Details Table 78. Sanofi Business Overview Table 79. Sanofi Product Table 80. Sanofi Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 81. Sanofi Recent Development Table 82. Qilu Pharma Company Details Table 83. Qilu Pharma Business Overview Table 84. Qilu Pharma Product Table 85. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 86. Qilu Pharma Recent Development Table 87. Teva Pharmaceutical Industries Ltd. Company Details Table 88. Teva Pharmaceutical Industries Ltd. Business Overview Table 89. Teva Pharmaceutical Industries Ltd. Product Table 90. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 91. Teva Pharmaceutical Industries Ltd. Recent Development Table 92. Taiji group Business Overview Table 93. Taiji group Product Table 94. Taiji group Company Details Table 95. Taiji group Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 96. Taiji group Recent Development Table 97. Novartis Company Details Table 98. Novartis Business Overview Table 99. Novartis Product Table 100. Novartis Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 101. Novartis Recent Development Table 102. Heron Therapeutics Company Details Table 103. Heron Therapeutics Business Overview Table 104. Heron Therapeutics Product Table 105. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 106. Heron Therapeutics Recent Development Table 107. Atnahs Pharma UK Limited Company Details Table 108. Atnahs Pharma UK Limited Business Overview Table 109. Atnahs Pharma UK Limited Product Table 110. Atnahs Pharma UK Limited Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 111. Atnahs Pharma UK Limited Recent Development Table 112. Mylan Company Details Table 113. Mylan Business Overview Table 114. Mylan Product Table 115. Mylan Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 116. Mylan Recent Development Table 117. Duchesnay Company Details Table 118. Duchesnay Business Overview Table 119. Duchesnay Product Table 120. Duchesnay Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 121. Duchesnay Recent Development Table 122. Tesaro Company Details Table 123. Tesaro Business Overview Table 124. Tesaro Product Table 125. Tesaro Revenue in Nausea And Vomiting Treatment Business (2015-2020) (Million US$) Table 126. Tesaro Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Nausea And Vomiting Treatment Market Share by Type: 2020 VS 2026 Figure 2. Serotonin Receptor Antagonist Features Figure 3. Neurokinin NK1 Receptor Antagonist Features Figure 4. Other Features Figure 5. Global Nausea And Vomiting Treatment Market Share by Application: 2020 VS 2026 Figure 6. CINV Case Studies Figure 7. PONV Case Studies Figure 8. Motion Sickness Case Studies Figure 9. Pregnancy Case Studies Figure 10. Others Case Studies Figure 11. Nausea And Vomiting Treatment Report Years Considered Figure 12. Global Nausea And Vomiting Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Nausea And Vomiting Treatment Market Share by Regions: 2020 VS 2026 Figure 14. Global Nausea And Vomiting Treatment Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Nausea And Vomiting Treatment Market Share by Players in 2019 Figure 17. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nausea And Vomiting Treatment as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Nausea And Vomiting Treatment Revenue in 2019 Figure 19. North America Nausea And Vomiting Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Nausea And Vomiting Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Nausea And Vomiting Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Nausea And Vomiting Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Merck & Co. Inc. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 25. Helsinn Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Helsinn Group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 27. Unimed Pharmaceuticals (AbbVie Inc.) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 29. Kyowa Kirin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Kyowa Kirin Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Sanofi Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 33. Qilu Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Qilu Pharma Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 35. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 37. Taiji group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Taiji group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 39. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Novartis Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 41. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Heron Therapeutics Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 43. Atnahs Pharma UK Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Atnahs Pharma UK Limited Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 45. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Mylan Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 47. Duchesnay Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Duchesnay Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 49. Tesaro Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Tesaro Revenue Growth Rate in Nausea And Vomiting Treatment Business (2015-2020) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Merck & Co. Inc. Helsinn Group Unimed Pharmaceuticals (AbbVie Inc.) Kyowa Kirin Sanofi Qilu Pharma Teva Pharmaceutical Industries Ltd. Taiji group Novartis Heron Therapeutics Atnahs Pharma UK Limited Mylan Duchesnay Tesaro